Tg Therapeutics TGTX
NASDAQ TGTX
$54.29 +0.67 (+1.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Cash & Current Investments (2011 - 2026)

Updated

Tg Therapeutics (TGTX) posted Cash & Current Investments of $612.3 million for Q2 2026, up 119.5% from $278.9 million a year earlier and up 6.9% from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Cash & Current Investments (2011 - 2026) Analysis & Trends

At the end of FY2025, Tg Therapeutics' Cash & Current Investments came in at $199.5 million, down 35.9% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of -19.9% (FY2020 to FY2025).
  • In prior years, Tg Therapeutics' Cash & Current Investments was $311 million in FY2024 (+43.0%), $217.5 million in FY2023 (+24.9%), $174.1 million in FY2022 (-50.3%) and $350.3 million in FY2021 (-42.1%).
  • The Q2 2026 figure stands as the highest quarterly Cash & Current Investments in data going back to Q4 2011.
  • On a year-over-year basis, Cash & Current Investments increased in six of the last eight quarters, with growth averaging 36.9%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q2 2026, with growth of 119.5%; the weakest was Q4 2022, with a decline of 50.3%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $572.8 million (Q1 2026), $199.5 million (Q4 2025) and $178.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Tg Therapeutics 8.31 Bn 7.70 Bn 199.14 Mn 612.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 612.30 Mn
Mar 31, 2026 572.80 Mn
Dec 31, 2025 199.50 Mn
Sep 30, 2025 178.30 Mn
Jun 30, 2025 278.90 Mn
Mar 31, 2025 276.20 Mn
Dec 31, 2024 311.00 Mn
Sep 30, 2024 341.00 Mn
Jun 30, 2024 217.30 Mn
Mar 31, 2024 209.80 Mn
Dec 31, 2023 217.50 Mn
Sep 30, 2023 229.20 Mn
Jun 30, 2023 144.90 Mn
Mar 31, 2023 139.70 Mn
Dec 31, 2022 174.10 Mn
Sep 30, 2022 197.70 Mn
Jun 30, 2022 231.80 Mn
Mar 31, 2022 280.70 Mn
Dec 31, 2021 350.30 Mn
Sep 30, 2021 381.40 Mn
API Access

Tg Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TGTX&period=max&api_key=YOUR_API_KEY